Skip to main content
OpenTrials

Clinical trial condition

Sexually Transmitted Diseases

Explore clinical trials studying Sexually Transmitted Diseases. Study availability and eligibility vary by location and protocol.

6,127 public trials 375 recruiting studies
Refine in advanced search Browse all conditions

Sexually Transmitted Diseases trial results

Completed

Study to Evaluate the Efficacy of the Human Papillomavirus Vaccine in Healthy Adult Women of 26 Years of Age and Older

NCT00294047

Conditions
Communicable Diseases, DNA Virus Infections, Disease Attributes, +23 more
Locations
  • GSK Investigational Site Fountain Valley, California, United States
  • GSK Investigational Site Aurora, Colorado, United States
  • GSK Investigational Site Golden, Colorado, United States
  • GSK Investigational Site Coral Gables, Florida, United States
View all 75 locations
View Trial Details
Completed

Immunogenicity of GlaxoSmithKline Biological's Human Papillomavirus (HPV) Vaccine (580299) Versus Merck's Gardasil® in Healthy Females 18-45 Years of Age

NCT00423046

Conditions
Communicable Diseases, DNA Virus Infections, Disease Attributes, +23 more
Locations
  • GSK Investigational Site Chandler, Arizona, United States
  • GSK Investigational Site San Diego, California, United States
  • GSK Investigational Site San Francisco, California, United States
  • GSK Investigational Site Vista, California, United States
View all 40 locations
View Trial Details
Completed

Human Papillomavirus Vaccine Immunogenicity and Safety Trial in Young Adult Women With GSK Biologicals Novel HPV Vaccine

NCT00359619

Conditions
Communicable Diseases, DNA Virus Infections, Disease Attributes, +12 more
Locations
  • GSK Investigational Site Denver, Colorado, United States
  • GSK Investigational Site Golden, Colorado, United States
  • GSK Investigational Site Salt Lake City, Utah, United States
  • GSK Investigational Site Salt Lake City, Utah, United States
View Trial Details
Completed

Evaluation of the Immune Responses of GSK Biologicals' HPV Vaccine Following Manufacturing Process Adaptation.

NCT00250276

Conditions
Communicable Diseases, DNA Virus Infections, Disease Attributes, +12 more
Locations
  • GSK Investigational Site Hvidovre, Denmark
  • GSK Investigational Site Kaunas, Lithuania
  • GSK Investigational Site Klaipėda, Lithuania
  • GSK Investigational Site Vilnius, Lithuania
View Trial Details
Completed

A Study to Evaluate the Efficacy and Safety of Glecaprevir/Pibrentasvir (ABT-493/ABT-530) in Treatment-Naive and Treatment-Experienced, Non-Cirrhotic Asian Adults With Chronic Hepatitis C Virus Genotype (GT) 1 to GT6 Infection With or Without Human Immunodeficiency Virus Co-Infection

NCT03222583

Conditions
Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Chronic Disease, +27 more
Locations
  • Peking University Peoples Hospit /ID# 156846 Beijing, Beijing Municipality, China
  • Guangzhou Eighth People's Hosp /ID# 156859 Guangzhou, Guangdong, China
  • Guangdong General Hospital /ID# 156822 Guangzhou, Guangdong, China
  • Nanfang Hospital of Southern Medical University /ID# 156860 Guangzhou, Guangdong, China
View all 48 locations
View Trial Details

Related conditions